VF
MYGN icon

Virtu Financial’s Myriad Genetics MYGN Stock Holding History

Virtu Financial’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$422K Buy
+93,668
New +$488K 0.02% 639
2024
Q1 		– Sell
-22,366
Closed -$428K – 1845
2023
Q4 		$428K Buy
+22,366
New +$387K 0.03% 458
2019
Q4 		$223K Buy
+8,176
New +$225K 0.02% 864
2019
Q2 		– Sell
-7,061
Closed -$234K – 1711
2019
Q1 		$234K Buy
+7,061
New +$215K 0.02% 920
2015
Q3 		– Sell
-8,818
Closed -$300K – 375
2015
Q2 		$300K Buy
+8,818
New +$300K 0.03% 260

Other funds holding MYGN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return